|
|
| Year : 1991 | Volume
: 36
| Issue : 3 | Page : 76-81 |
|
|
Drug therapy for cysticercosis : cutaneous and neurocutaneous
PN Arora, PC Sancheti, KR Ramakrishanan, S. Venkataraman
Departments of Dermatology and Neurology, Base & Army Hospital Complex, Delhi Cantt-110010
Correspondence Address:
PN Arora
Departments of Dermatology and Neurology, Base & Army Hospital Complex, Delhi Cantt-110010
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
ABSTRACT: Diagnosis of cysticercosis was established in 27 cases based on clinical evaluation and histopathological examination of skin biopsy. cutaneous cysts were present in all the 27 cases. seizure in 23, raised intracranial tension in 9 and meningoencephalitis in 2. CT scan was suggestive of intracranial cysticercosis in 25 cases. Praziquantel was administered in a dose of 50 mg/kg body wt/day for 15 days alongwith steroids in 22 cases. Follow up which ranged between 3 months to 2 years revealed complete response in 4 patients within a period of six months and partial response in 8 patients. Severe side effects were recorded in 9, moderate in 5 and mild in 4. No side effects were recorded in 4 patients. 5 patients were treated with albendazole 400 mg twice daily for 7 days when cutaneous integument alone was involved in 2 patients; and remaining 3 for 30 days when central nervous system was involved alongwith. There was partial response in all the 5 patients. Side effects recorded were moderate. The use of drugs offers pharmacological treatment of cysticercosis with reasonably high rate of success. |
|
|
|
| [PDF Not available]* |
|
 |
|
